Synthetic DNA-encoded checkpoint inhibitor antibodies advance cancer immunotherapy
PHILADELPHIA -- (Oct. 4, 2018) --Wistar scientists and collaborators demonstrate for the first time that through engineering constructs, they can express DNA-encoded monoclonal antibodies (DMAbs)...








